Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
17,532,227
-
Share change
-
+1,547,425
-
Total reported value
-
$9,991,000
-
Price per share
-
$0.57
-
Number of holders
-
38
-
Value change
-
+$910,076
-
Number of buys
-
15
-
Number of sells
-
16
Institutional Holders of THRESHOLD PHARMACEUTICAL INC - COM NEW (THLD) as of Q1 2017
As of 31 Mar 2017,
THRESHOLD PHARMACEUTICAL INC - COM NEW (THLD) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,532,227 shares.
The largest 10 holders included
First Eagle Investment Management, LLC, VANGUARD GROUP INC, DEERFIELD MANAGEMENT CO, BlackRock Inc., Cormorant Asset Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, Rhenman & Partners Asset Management AB, and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM.
This page lists
38
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.